Canada· CA-DIN-02497247
CABENUVA
A antivirals for treatment of hiv infections, combinations product containing cabotegravir + rilpivirine, registered in Canada by VIIV HEALTHCARE ULC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CABOTEGRAVIR + RILPIVIRINE
- Manufacturer
- VIIV HEALTHCARE ULC
- Country
- Canada (CA)
- ATC code
- J05AR
- ATC class
- Antivirals for treatment of HIV infections, combinations
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J05AR
Antivirals for treatment of hiv infections, combinations, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1aff4b39-444a-4372-8cba-cc057b16a173 GET /v1/drugs/1aff4b39-444a-4372-8cba-cc057b16a173?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02497247",
"form": "SUSPENSION (EXTENDED-RELEASE)",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J05AR",
"schedule": [
"Prescription"
],
"drug_code": "98709",
"strengths": [
"200 MG",
"300 MG"
],
"ahfs_class": null,
"substances": [
"CABOTEGRAVIR",
"RILPIVIRINE"
],
"product_categorization": null
}See everything about cabotegravir + rilpivirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.